XERS
Xeris BiopharmaBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
XERS vs peer average
68/100
XERS vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
CDNA is the first available peer comparator.
Primarily a size peer rather than an operating comp; diagnostics reimbursement and testing-utilization dynamics differ meaningfully from Xeris' branded-product commercial model.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XERS
Xeris Biopharma
CDNA
CareDx
Grade
B
B
Momentum
36
78
Value
59
50
Sentiment
81
56
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs CDNA
XERS / CDNA
Grade Position
In line
XERS vs. peer average (B vs. C)
68/100
Momentum
36
CDNAValue
59
XERSSentiment
81
XERSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XERS
CDNA is the first peer returned for this comparison set.

